(19)
(11) EP 1 237 548 A1

(12)

(43) Date of publication:
11.09.2002 Bulletin 2002/37

(21) Application number: 00978419.0

(22) Date of filing: 08.11.2000
(51) International Patent Classification (IPC)7A61K 31/17, A61K 31/27, C07C 271/20, C07C 275/30
(86) International application number:
PCT/US0030/668
(87) International publication number:
WO 0103/4141 (17.05.2001 Gazette 2001/20)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 09.11.1999 US 164350 P

(71) Applicant: SmithKline Beecham Corporation
Philadelphia, PA 19103 (US)

(72) Inventors:
  • MCCLELAND, Brent, W.
    Greenlane, PA 18054 (US)
  • WIDDOWSON, Katherine, L.
    King of Prussia, PA 19406 (US)

(74) Representative: Quillin, Helen Kaye et al
GlaxoSmithKlineCorporate Intellectual Property (CN9.25.1)980 Great West Road
Brentford, Middlesex TW8 9GS
Brentford, Middlesex TW8 9GS (GB)

   


(54) IL-8 RECEPTOR ANTAGONISTS